Related Experiment Video
Updated: Jan 16, 2026

10:01
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
7.9K
High-grade endometrial stromal sarcoma presenting with multiple brain metastases: a case report
Hina Kono1, Masafumi Toyoshima2, Ai Ikki1
1Department of Obstetrics and Gynecology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.
Journal of Medical Case Reports
|September 26, 2025
Summary
High-grade endometrial stromal sarcoma rarely presents with brain metastases as the initial symptom. This aggressive uterine sarcoma has a poor prognosis, even with treatment, emphasizing the need for clinical vigilance.
Area of Science:
- Gynecologic Oncology
- Neuropathology
- Oncologic Imaging
Background:
- High-grade endometrial stromal sarcoma (HGESS) is a rare, aggressive uterine malignancy with a poor prognosis.
- Typical symptoms include abnormal vaginal bleeding and abdominal discomfort.
- Initial presentation with distant metastases, especially to the brain, is exceptionally uncommon.
Purpose of the Study:
- To report a unique case of HGESS presenting initially with neurological symptoms due to brain metastases.
- To highlight the diagnostic challenges and importance of considering HGESS in the differential diagnosis of brain metastases.
Main Methods:
- Detailed clinical case presentation of a 58-year-old woman with HGESS.
- Diagnostic workup included cranial CT, craniotomy, tumor resection, PET-CT, and CT-guided endometrial biopsy.
- Pathological and imaging findings were analyzed, including potential origin from adenomyosis.
Main Results:
- The patient presented with left hemiparesis and weight loss, found to have multiple brain tumors.
- Uterus identified as the primary site; HGESS confirmed via CT-guided biopsy after initial negative results.
- Rapid deterioration and death occurred within 4 months despite chemotherapy and radiosurgery.
Conclusions:
- Atypical presentation with neurological symptoms significantly delayed diagnosis.
- Clinicians must maintain a high index of suspicion for HGESS in patients with brain metastases, irrespective of gynecological symptoms.
- This case underscores the aggressive nature and poor prognosis of HGESS presenting with metastatic disease.

